Chas Mc Khann
Chief Executive Officer @ Silk Road Medical
Chas Mc Khann is the Chief Executive Officer of Silk Road Medical, Inc. in Sunnyvale, California, with over 25 years of experience in the medical technology industry.
Chief Executive Officer at Silk Road Medical
Chas Mc Khann currently serves as the Chief Executive Officer at Silk Road Medical, Inc., located in Sunnyvale, California, United States. He oversees the strategic direction and operational management of the company. Silk Road Medical focuses on innovative technologies to treat and prevent strokes related to carotid artery disease.
Leadership at Apollo Endosurgery
Chas Mc Khann was the President and CEO of Apollo Endosurgery from 2021 to 2023. During his tenure, he was responsible for crafting and driving forward a transformational growth strategy. His leadership culminated in the acquisition of Apollo Endosurgery by Boston Scientific in April 2023. Apollo Endosurgery specialized in devices for minimally invasive bariatric and gastrointestinal procedures.
Professional Journey at Torax Medical
Chas Mc Khann served as the Chief Commercial Officer at Torax Medical, Inc. from 2016 to 2017. In this role, he managed the commercialization efforts for the company's innovative products. His contributions were pivotal until the company's acquisition by Johnson & Johnson. Prior to that, from 2015 to 2016, he led similar initiatives as Chief Commercial Officer at Intersect ENT.
Academic Background at Stanford University
Chas Mc Khann holds an MBA from Stanford University Graduate School of Business, which he completed between 1996 and 1998. Earlier, he earned a BA in Political Science and Economics from Stanford University from 1987 to 1991. His academic background has laid a strong foundation for his impactful career in business and the life sciences industry.
Extensive Experience in Marketing and Strategy
Chas Mc Khann has over 25 years of experience in developing effective growth strategies and achieving notable results. His expertise spans sales, marketing, reimbursement, international market entry, business development, M&A, and building strong organizational cultures. He has held significant roles, including Worldwide Vice President of Marketing for cardiac rhythm management at Boston Scientific, where he managed various high-profile projects.
